In Brief: Senna laxatives
This article was originally published in The Tan Sheet
Executive Summary
Senna laxatives: Nonprescription Drug Manufacturers Association receives FDA notification that a feedback letter regarding senna safety data submitted by Purdue Frederick will be issued in the near future. The agency explains that it still is reviewing human data included in the May 28, 1996 letter from the Norwalk, Conn.-based manufacturer of Senokot and Gentlax and will not schedule the feedback meeting requested by NDMA until it has issued its feedback letter ("The Tan Sheet" Nov. 18, 1996, p. 5)...